BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$12.81M
↑ 115% above average
Average (9y)
$-86.57M
Historical baseline
Range
High:$12.81M
Low:$-167.56M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $12.81M | +111.0% |
| 2023 | $-116.33M | +19.1% |
| 2022 | $-143.85M | -18.2% |
| 2021 | $-121.74M | +27.3% |
| 2020 | $-167.56M | -74.0% |
| 2019 | $-96.28M | -6.5% |
| 2018 | $-90.36M | -59.9% |
| 2017 | $-56.51M | -17.3% |
| 2016 | $-48.17M | -28.0% |
| 2015 | $-37.64M | - |